Record levels of funding propel Denver-Boulder to the top of the life sciences market

[ad_1] This story is part of CNBC’s quarterly Cities of Success series, which explores cities that have transformed into business hubs with an entrepreneurial spirit that has attracted capital, companies and employees. The Denver-Boulder region is rapidly emerging as a major hub for the life sciences industry, attracting companies that develop cutting-edge medical treatments and…

Read More

AI can drive efficiency, but raises market concentration concerns: CCI chief Ravneet Kaur

[ad_1] Artificial intelligence and machine learning can drive efficiency and innovation but also raise concerns related to market concentration and potential anti-competitive behaviour, according to CCI chief Ravneet Kaur. The watchdog CCI, which has the mandate to curb anti-competitive ways and foster fair competition, will soon commission a study to look at all aspects of…

Read More

China-based hackers will disrupt India elections with AI-generated content, warns Microsoft

[ad_1] With major elections taking place around the world this year, particularly in India, South Korea and the US, a Microsoft Threat Analysis team has warned that China will create and amplify AI-generated content to benefit its interests. Despite the chances of such content in affecting election results remaining low, China’s increasing experimentation in augmenting…

Read More

Diabetes drug similar to Ozempic helped slow progression of Parkinson’s disease in small trial

[ad_1] The coronal view of a human brain of a patient suffering from Parkinson’s disease Sherbrooke Connectivity Imaging Lab | Getty Images A highly popular class of drugs for diabetes and obesity is showing early potential to help patients with Parkinson’s disease, too.  An older diabetes treatment called lixisenatide helped slow the progression of motor…

Read More